Barinthus Biotherapeutics plc. Quarterly Return On Assets in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
  • Barinthus Biotherapeutics plc. Return On Assets for the quarter ending September 30, 2024 was -29.3 %, a 4.41% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Return On Assets for 2023 was -30.8 %, a 1710% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Return On Assets for 2022 was 1.91 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -29.3 +1.35 +4.41% Jul 1, 2024 Sep 30, 2024
Q2 2024 -30.7 -9.86 -47.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -31.8 -26.1 -462% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.8 -32.7 -1710% Oct 1, 2023 Dec 31, 2023
Q3 2023 -30.7 -34.7 -857% Jul 1, 2023 Sep 30, 2023
Q2 2023 -20.9 -20.4 -4084% Apr 1, 2023 Jun 30, 2023
Q1 2023 -5.65 +6.54 +53.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 1.91 +23 Oct 1, 2022 Dec 31, 2022
Q3 2022 4.05 +29.3 Jul 1, 2022 Sep 30, 2022
Q2 2022 -0.5 Apr 1, 2022 Jun 30, 2022
Q1 2022 -12.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -21.1 Oct 1, 2021 Dec 31, 2021
Q3 2021 -25.2 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.